Narrative review / 2012
A review discusses clinical decisions for radioactive iodine therapy, including pretherapy low-iodine diet in thyroid disease management.
This review summarizes management decisions made by endocrinologists during radioactive iodine (RAI) therapy for hyperthyroidism and differentiated thyroid cancer. Pretherapy decisions covered include the use of antithyroid medications and a low-iodine diet based on supportive literature. It also highlights guideline changes and recent randomized controlled trials modifying how RAI is used for remnant ablation and adjuvant therapy to help limit radiation exposure.
- Study type
- Narrative review
- Who was studied
- Patients with hyperthyroidism and differentiated thyroid cancer
- What was measured
- Management decisions and clinical practice of radioactive iodine (RAI) therapy
THE PAPER
Radioactive iodine therapy.
Lee SL. Curr Opin Endocrinol Diabetes Obes, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.